DekaBank Deutsche Girozentrale
TIL icon

DekaBank Deutsche Girozentrale’s Instil Bio TIL Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-440
Closed -$40K – 1437
2022
Q2 		$40K Hold
440
– – ﹤0.01% 1323
2022
Q1 		$103K Buy
440
+40
+10% +$9.35K ﹤0.01% 1270
2021
Q4 		$132K Buy
+400
New +$154K ﹤0.01% 1317

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

DekaBank Deutsche Girozentrale's TIL Position: Q3 2022 in Review

DekaBank Deutsche Girozentrale sold out of Instil Bio (TIL) in Q3 2022, closing a stake of 440 shares — an estimated $40K sold.

DekaBank Deutsche Girozentrale first reported a position in TIL in Q4 2021 and held it in 3 quarters. The position peaked at $132K in Q4 2021. 95 funds tracked by Wall St. Rank hold TIL as of Q3 2022.

  • DekaBank Deutsche Girozentrale reported no remaining Instil Bio position as of Q3 2022 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 440 Instil Bio shares in Q3 2022, an estimated $40K.
  • DekaBank Deutsche Girozentrale first reported a position in Instil Bio in Q4 2021 and held it in 3 quarters.
  • DekaBank Deutsche Girozentrale's Instil Bio position peaked at $132K in Q4 2021.
  • 95 funds tracked by Wall St. Rank held Instil Bio as of Q3 2022.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2022, filed 2 Nov 2022.